Translational Development AcTDACU
13F holders, Q4 2025 (December 31)5holders −2
0new positions
2sold out
1famous investor
$11.09avg. 13F price*
At the end of Q4 2025, 5 institutions reported holding Translational Development Ac (TDACU) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holders were Calamos Advisors LLC ($4.4M), D. E. Shaw & Co. ($3.7M) and Yakira Capital Management, Inc. ($639K). One famous investor held it David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Translational Development Ac
- CUSIP
- G9008W121
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $7.3M |
All 13F filers, Q3 2025 → Q4 2025: 9 shares bought and 701,700 shares sold, net −701,691 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Calamos Advisors LLC | 0.03% | No change | 375,000 | $4.4M |
| D. E. Shaw & Co. | 0.00% | No change | 350,000 | $3.7M |
| Yakira Capital Management, Inc. | 0.22% | No change | 60,000 | $639K |
| Flow Traders U.S. LLC | 0.00% | Reduce -10.8% | 14,087 | $148K |
| UBS Group AG | 0.00% | Add +0.1% | 8,339 | $88K |
"% of holder's portfolio" is TDACU's weight in each manager's 13F, not the share of Translational Development Ac the manager owns.